肝细胞癌中个体内CT与MRI的LI-RADS分类一致性与不一致性的预后意义
这项双中心回顾性研究纳入319例术前同时接受CT和MRI的肝细胞癌患者,评估两种检查LI-RADS分类的一致性与不一致性及其与术后2年无复发生存率的关系。结果显示35.7%患者CT与MRI分类不一致,MRI的LR-M分类更常见(21.6% vs 6.0%),两种检查的LR-M分类均独立与2年RFS相关,双模态均为LR-M者RFS最低(33.3%)。
要点
- 约35.7%的肝细胞癌患者CT与MRI的LI-RADS分类不一致,阅片报告时需注意模态间差异。
- MRI的LR-M分类比例高于CT(21.6% vs 6.0%),MRI可能更易判定为LR-M。
- CT或MRI任一模态为LR-M均独立与2年RFS相关,双模态LR-M者2年RFS最低(33.3%)。
核心结论
- 肝细胞癌的LI-RADS分类在CT与MRI间常不一致;任一模态的LR-M分类均独立与2年RFS相关,双模态均为LR-M时生存最低。
研究设计与样本
- 双中心回顾性研究,纳入2016年1月至2020年12月间术前同时接受CT和MRI并接受肝切除的肝细胞癌患者319例(平均年龄58.8岁±9.7[SD],男性248例)。
诊断标准与关键数值
- 对每个肝细胞癌病灶分别在CT和MRI上独立判定LI-RADS分类,以LR-M vs LR-4/5为分组变量;CT的LR-M比例为6.0%,MRI的LR-M比例为21.6%(P < .001);CT LR-M与2年RFS的HR为2.24(P = .03),MRI LR-M与2年RFS的HR为2.33(P = .002);双模态均为LR-M者2年RFS为33.3%,仅一个模态为LR-M者为63.3%,均非LR-M者为82.8%(P < .001)。
临床应用与阅片要点
- 阅片和报告时应同时关注CT与MRI的LI-RADS分类结果,若任一模态判为LR-M提示术后复发风险较高;双模态均为LR-M者2年RFS最低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the intraindividual concordance and discordance in Liver Imaging Reporting and Data System (LI-RADS) categorizations between CT and MRI for surgically resected hepatocellular carcinoma (HCC) and to evaluate their association with early postsurgical recurrence. Materials and Methods This dual-center retrospective study included patients who underwent both CT and MRI before hepatic resection for HCC between January 2016 and December 2020. For each HCC lesion, the LI-RADS category was independently assigned at CT and MRI. Univariable and multivariable Cox regression analyses were performed to evaluate the associations between the CT and MRI LI-RADS categorizations (LI-RADS category M [LR-M] vs LI-RADS category 4 or 5 [LR-4/5]) and 2-year recurrence-free survival (RFS) rate. Patients were classified into three groups according to the CT or MRI LI-RADS categorization: LR-M at both CT and MRI, at only one modality, or at neither CT or MRI. The 2-year RFS was compared among the groups. Results A total of 319 patients (mean age, 58.8 years ± 9.7 [SD]; 248 male patients) were included, with HCC lesions of 114 (35.7%) patients showing discrepant CT or MRI LI-RADS categorizations. LR-M categorization was more common at MRI than at CT (21.6% vs 6.0%; P < .001). Both CT (hazard ratio, 2.24; P = .03) and MRI (hazard ratio, 2.33; P = .002) LR-M categorizations were independently associated with the 2-year RFS rate. The 2-year RFS rate was lowest, intermediate, and highest in patients with HCC lesions categorized as LR-M at both modalities (33.3%), only one modality (63.3%), and neither modality (82.8%), respectively (P < .001). Conclusion LI-RADS categorization of HCC often differed between CT and MRI. LR-M categorization at either modality was independently associated with 2-year RFS, with the lowest survival observed when lesions were classified as LR-M with both modalities. Keywords: Hepatocellular Carcinoma, Liver Imaging Reporting and Data System, CT, MRI, Prognosis Supplemental material is available for this article. © RSNA 2026.
引用
- Jung YJ, Kim S, Song IH, et al. Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma. Radiol Imaging Cancer. 2026. PMID: 41891826. doi:10.1148/rycan.250645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。